CoChat

Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction

Open access
Yuferov, Vadim, Fussell, David, LaForge, K Steven, Nielsen, David A, Gordon, Derek, Ho, Ann, Leal, Suzanne M, Ott, Jurg, Kreek, Mary Jeanne · 2004 · Pharmacogenetics

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

The kappa opioid receptor (KOR) plays a role in stress responsivity, opiate withdrawal and responses to cocaine. KOR activation by its endogenous ligand dynorphin A(1-17) decreases basal and drug-induced striatal levels of dopamine. The complete structure of the human KOR gene (hOPRK1) has not been previously determined. This study: (i) characterized the genomic structure of the hOPRK1 gene; (ii) identified single nucleotide polymorphisms (SNPs) in the hOPRK1 gene; and (iii) investigated possible associations of these variants with vulnerability to develop heroin addiction. Analysis of 5'-RACE cDNA clones revealed the presence of a novel exon 1 ranging in length from 167 to 251 nucleotides in the 5' 5'-untranslated region of the hOPRK1 mRNA. We found that the hOPRK1 gene has four major exons and three introns, similar to rodent OPRK1 genes. Direct sequencing of amplified DNA containing all four exons and intron 1 of the hOPRK1 gene were evaluated for polymorphisms in 291 subjects (145 former heroin addicts and 146 controls). Twelve SNPs were identified, nine novel variants and three previously reported SNPs. Using logistic regression with opioid dependence as the dependent variable, the 36G>T SNP exhibited a point-wise significant association (P = 0.016) with disease status. The number of haplotypes seen in the three ethnic groups were nine, six and five for African-Americans, Caucasians, and Hispanics, respectively, with corresponding significance levels for differences in haplotype frequencies between cases and controls of P = 0.0742, 0.1015 and 0.0041. Combining ethnicities by Fisher's method yields an empirical significance level of P = 0.0020.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00008571-200412000-00002

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 7

  1. Kreek, 1996, Mol Psychiatry, 1, 232
  2. Kreek, 1999, J Pharmacol Exp Ther, 288, 260
  3. Butelman, 1999, J Pharmacol Exp Ther, 290, 678
  4. Claye, 1997, NIDA Res Monogr, 174, 113
  5. Maisonneuve, 1995, J Pharmacol Exp Ther, 272, 652
  6. Wei, 2000, Mol Pharmacol, 57, 401
  7. Duan, 2003, Hum Mol Genet, 12, 205, 10.1093/hmg/ddg055 · doi:10.1093/hmg/ddg055 · Paper page

Cited by

See all 128

Metadata

Authors
Yuferov, V., Fussell, D., LaForge, K. S., Nielsen, D. A., Gordon, D., Ho, A., Leal, S. M., Ott, J., & Kreek, M. J.
Affiliations
National Institute on Drug Abuse (US)
Corresponding author
Yuferov, Vadim
Venue
Pharmacogenetics
Published
2004-12
Volume
14
Issue
12
Pages
793-804
ISSN
0960-314X (ISSN-L)
OpenAlex
W1975031360
Cited by
128
References
50
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 5 · 2015: 2 · 2014: 11 · 2013: 11 · 2012: 6
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Pharmacogenetics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (2m01rr000102-41)
  • National Institute of Mental Health (R01MH044292, MH 44292, R37MH044292)
  • National Institute on Drug Abuse (R01DA012848, K05 DA00049, K05DA000049, DA12848)
  • National Human Genome Research Institute (K01 HG00055, K01HG000055)
  • National Center for Research Resources (M01-RR000102, M0-1 RR00102)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
kappa opioid receptor, gene structure, exon 1, single nucleotide polymorphisms, haplotypes, heroin addiction, opioid use disorder, genetic association, dynorphin A(1-17), 5' untranslated region
MeSH terms
Base Sequence, Black or African American, Exons, Female, Gene Frequency, Haplotypes, Hispanic or Latino, Humans, Introns, Male, Molecular Sequence Data, Opioid-Related Disorders, New York, Sequence Homology, Nucleic Acid, Genetic Variation, Linkage Disequilibrium, Receptors, Opioid, kappa, Patient Selection, 5' Untranslated Regions, Polymorphism, Single Nucleotide, Black People, White People, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. https://app.cochat.ai/papers/10.1097/00008571-200412000-00002
The paper
Yuferov, V., Fussell, D., LaForge, K. S., Nielsen, D. A., Gordon, D., Ho, A., Leal, S. M., Ott, J., & Kreek, M. J. (2004). Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics. https://doi.org/10.1097/00008571-200412000-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.